Haemostatic variables in arterial hypertension

Area of Science:

• Cardiology
• Hematology
• Biochemistry

Background:

• Essential hypertension is a common cardiovascular risk factor.
• Understanding early molecular changes in hypertension is crucial for timely intervention.
• Coagulation and fibrinolysis markers may be altered in hypertensive states.

Purpose of the Study:

• To investigate plasma levels of key hemostatic markers in untreated essential hypertension.
• To compare these markers between hypertensive patients and normotensive controls.
• To identify potential early indicators of endothelial dysfunction in hypertension.

Main Methods:

• Plasma levels of thrombomodulin (TM), beta-thromboglobulin (beta-TG), D-dimer (DD), tissue-type plasminogen activator (t-PA), and plasminogen activator-inhibitor (PAI-1) were measured.
• 22 untreated patients with uncomplicated essential hypertension were studied.
• 10 normotensive subjects served as controls.

Main Results:

• No significant differences were observed in plasma TM, plasma and urine beta-TG, or plasma DD between hypertensive patients and controls.
• Significantly higher levels of t-PA and PAI-1 were detected in hypertensive patients compared to normotensive controls.
• These findings suggest a specific alteration in the fibrinolytic system during early essential hypertension.

Conclusions:

• Early stages of essential hypertension are associated with elevated levels of t-PA and PAI-1.
• These changes in the fibrinolytic system may reflect early endothelial activation or dysfunction.
• Further research is warranted to explore the clinical implications of these findings in hypertension management.